4.3 Editorial Material

Predicting the response to anti-PD1 therapy in metastatic melanoma

Journal

TRANSLATIONAL CANCER RESEARCH
Volume 5, Issue -, Pages S576-S579

Publisher

AME PUBL CO
DOI: 10.21037/tcr.2016.09.40

Keywords

-

Categories

Funding

  1. BMS
  2. MSD
  3. Roche
  4. Novartis
  5. Amgen
  6. Merck

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available